恆智控股(08405.HK):安永將退任核數師 尤尼泰•栢淳補缺
格隆匯3月26日丨恆智控股(08405.HK)宣佈,待目前任期屆滿後,安永會計師事務所(”安永“)將退任公司核數師,自公司應屆股東周年大會(預期將於2022年5月27日舉行)結束起生效,並將不會膺選續聘為公司核數師。安永自2015年起一直擔任公司的核數師,故董事會認為適時輪換核數師為良好的企業管治常規以確保核數師的獨立性。
董事會於考慮公司審核委員會的推薦建議後決議(i)更換公司核數師,自公司應屆股東周年大會結束起生效;及(ii)建議委聘尤尼泰•栢淳(香港)會計師事務所擔任公司的新任核數師,任期至公司下屆股東周年大會結束時為止,惟須待公司股東於股東周年大會上批准後,方可作實。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.